Competitor Analysis: CD30 Antibodies

Published by: La Merie S.L.

Published: Jan. 26, 2009 - 3 Pages

Table of Contents

• CD30 Antibodies in Oncology
• About La Merie
  

Abstract

The present Competitive Intelligence Report about anti-CD30 antibody-based constructs used to treat lymphomas provides a competitor evaluation in the field of R&D projects with anti-CD30 antibodies as of January 2009.

The report includes a compilation of current active projects in research and development of anti-CD22 antibodies. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category/Therapeutic Area,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.
  

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.